Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

LGC Mikromol™LGC Mikromol™
VS
MANKIND PHARMA LTDMANKIND PHARMA LTD
LGC Mikromol™

LGC Mikromol™

Louis-Pasteur-Straße 30, Luckenwalde, 14943, DE

Last Update: 09/12/2025

View Profile
754/1000Fair

At Mikromol we combine an incomparable depth of pharmaceutical knowledge with 25 years of manufacturing experience and scientific acumen to ensure our portfolio of over 5,000 Impurity, Active Pharmaceutical Ingredient (API) and Excipient reference standards is of the hi...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:10
12-month incidents
0
Known data breaches
0
Attack type number
0
MANKIND PHARMA LTD

MANKIND PHARMA LTD

Phase 3, New Delhi, IN

Last Update: 06/09/2026

View Profile
Between 750 and 799
http://www.mankindpharma.com
781/1000Fair

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:19,230
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
LGC Mikromol™

LGC Mikromol™

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
MANKIND PHARMA LTD

MANKIND PHARMA LTD

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for LGC Mikromol™ in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MANKIND PHARMA LTD in 2026.

Incidents

Incident History - LGC Mikromol™ (X = Date, Y = Severity)

LGC Mikromol™ cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - MANKIND PHARMA LTD (X = Date, Y = Severity)

MANKIND PHARMA LTD cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
LGC Mikromol™

LGC Mikromol™

Incidents
No explicit notable incidents reported.
MANKIND PHARMA LTD

MANKIND PHARMA LTD

Incidents
No explicit notable incidents reported.

FAQ

Between LGC Mikromol™ company and MANKIND PHARMA LTD company, which one has the best AI Cybersecurity Score ?
Between LGC Mikromol™ company and MANKIND PHARMA LTD company, which one has experienced more cyber incidents in the past ?
Between LGC Mikromol™ company and MANKIND PHARMA LTD company, which one has experienced more cyber incidents this year ?
Between LGC Mikromol™ company and MANKIND PHARMA LTD company, which one has experienced at least one ransomware attack ?
Between LGC Mikromol™ company and MANKIND PHARMA LTD company, which one has experienced at least one data breach ?
Between LGC Mikromol™ company and MANKIND PHARMA LTD company, which one has experienced at least one targeted cyberattack ?
Between LGC Mikromol™ company and MANKIND PHARMA LTD company, which one has experienced at least one vulnerability ?
Between LGC Mikromol™ company and MANKIND PHARMA LTD company, which one holds the most compliance certifications ?
Between LGC Mikromol™ company and MANKIND PHARMA LTD company, which one holds the fewest compliance certifications ?
Between LGC Mikromol™ company and MANKIND PHARMA LTD company, which one has the most subsidiaries ?
Between LGC Mikromol™ company and MANKIND PHARMA LTD company, which one has the largest number of employees ?
Between LGC Mikromol™ and MANKIND PHARMA LTD, which company holds both SOC 2 Type 1 certifications ?
Between LGC Mikromol™ and MANKIND PHARMA LTD, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - LGC Mikromol™ or MANKIND PHARMA LTD ?
Which company is PCI DSS compliant - LGC Mikromol™ or MANKIND PHARMA LTD ?
Between LGC Mikromol™ and MANKIND PHARMA LTD, which company complies with HIPAA regulations for healthcare data ?
Between LGC Mikromol™ and MANKIND PHARMA LTD, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-93892
SUMMARY

IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to exposure of session tokens in the HTML response.

PUBLISHED
Date2026-10-12
UPDATED
Date2026-10-12
RISK INFORMATION (Score: 8.1)
CVSS3
Base Score: 8.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N
IMPACT SCORE
5.2
EXPLOITABILITY
2.8
CVE-2026-93891
SUMMARY

IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to an XML external entity (XXE) injection flaw.

PUBLISHED
Date2026-10-12
UPDATED
Date2026-10-12
RISK INFORMATION (Score: 7.6)
CVSS3
Base Score: 7.6
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:H/I:N/A:L
IMPACT SCORE
4.7
EXPLOITABILITY
2.3
CVE-2026-92832
SUMMARY

IBM Aspera Enterprise WebApps 1.0.0 through 1.0.6 could allow a local attacker to obtain sensitive information due to cleartext transmission of sensitive information.

PUBLISHED
Date2026-10-12
UPDATED
Date2026-10-12
RISK INFORMATION (Score: 5.1)
CVSS3
Base Score: 5.1
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
IMPACT SCORE
2.5
EXPLOITABILITY
2.5
CVE-2026-85457
SUMMARY

IBM Planning Analytics 2.0, and 2.1 could allow a remote authenticated attacker to execute arbitrary code due to a stack-based buffer overflow.

PUBLISHED
Date2026-10-12
UPDATED
Date2026-10-12
RISK INFORMATION (Score: 8.1)
CVSS3
Base Score: 8.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N
IMPACT SCORE
5.2
EXPLOITABILITY
2.8
CVE-2026-84418
SUMMARY

IBM DataStage on Cloud Pak for Data 5.4.0.0 can allow a man-in-the-middle attacker to present a forged TLS certificate, intercept the connection, and capture the IAM bearer Authorization header automatically attached by the session adapter. The captured token grants full platform-scope tenant API access, enabling the attacker to read and manipulate the victim's DataStage projects, flows, assets, and pipeline definitions. This is client-side SDK code running on the user's own machine, so exploitation requires an external network interceptor rather than a co-tenant in the shared cluster.

PUBLISHED
Date2026-10-12
UPDATED
Date2026-10-12
RISK INFORMATION (Score: 7.4)
CVSS3
Base Score: 7.4
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N
IMPACT SCORE
5.2
EXPLOITABILITY
2.2